These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13524523)

  • 1. [Studies on a factor in human gastric carcinoma tissue inhibiting the catalase activity of the mouse liver].
    YAMAGUCHI I; SATO J; ABE H
    Gan; 1957 Dec; 48(4):596-8. PubMed ID: 13524523
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic substances in cancer. IV. On a factor in gastric carcinoma tissue inhibiting the catalase activity of the mouse liver.
    OH-UTI K; SATO J; ABE H
    Tohoku J Exp Med; 1957 Dec; 67(1):97-103. PubMed ID: 13529967
    [No Abstract]   [Full Text] [Related]  

  • 3. The in vitro inhibition of hepatic catalase by boiled aqueous extracts from a human carcinoma of the stomach and from human non-malignant stomach epithelium.
    BROWN E
    Arch Biochem Biophys; 1959 Jun; 82(2):335-9. PubMed ID: 13661958
    [No Abstract]   [Full Text] [Related]  

  • 4. [Behaviour of protoporphyrin in relation to catalase activity and O2-uptake of sarcoma 180-bearing mouse liver].
    OKAMURA N; SATO K
    Gan; 1957 Dec; 48(4):606-7. PubMed ID: 13524529
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the liver catalase of malignant tumor animals. 3. Effect of vitamin B2 on the liver catalase activity of malignant tumor animals.
    YAMAMOTO S; ISHIHARA M; HASHIYAMA T
    Gan; 1957 Dec; 48(4):460-2. PubMed ID: 13524453
    [No Abstract]   [Full Text] [Related]  

  • 6. [Liver catalase and liver non-hemin iron in gastric cancer].
    SASORI T
    Gan; 1956 Dec; 47(3-4):294-5. PubMed ID: 13415007
    [No Abstract]   [Full Text] [Related]  

  • 7. [The influence of anticancer substances on the liver catalase activity and on the spleen of the tumor-bearing mice].
    OKAZAKI T
    Gan; 1957 Dec; 48(4):457-60. PubMed ID: 13524452
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver catalase activity in gastric cancer patients, in relation to the classified types of gastric carcinoma and pathological changes of liver.
    HISHIKAWA S
    Gan; 1959 Sep; 50():309-20. PubMed ID: 14402033
    [No Abstract]   [Full Text] [Related]  

  • 9. [The influence of liver- or RES-function on the catalase activity and free porphyrin content of tissue and blood of rats inoculated with Sasaki-ascites-hepatoma].
    SEINO S; KAWASHIMA T; SYOJI K; SATO Y
    Gan; 1957 Dec; 48(4):608-10. PubMed ID: 13524530
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical studies on liver catalase activity gastric carcinoma cases. II. Experimental supplements.
    YAMAGUCHI I
    Tohoku J Exp Med; 1959 Sep; 70():305-10. PubMed ID: 13846393
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormonal balance and liver catalase activity.
    TROOP RC
    Endocrinology; 1958 Apr; 62(4):385-90. PubMed ID: 13524155
    [No Abstract]   [Full Text] [Related]  

  • 12. The isolation of a basic protein having toxohormone activity from tumor tissues.
    FUJII S; KAWACHI T; OKUDA H; HAGA B; YAMAMURA Y
    Gan; 1960 Sep; 51():223-9. PubMed ID: 13702462
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical studies on liver catalase activity in gastric carcinoma cases. I. Clinical observations.
    YAMAGUCHI I
    Tohoku J Exp Med; 1959 Aug; 70():291-304. PubMed ID: 13846394
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the relation of the types of gastric cancer to liver catalase activity, and histochemical change in the liver].
    AIZAWA S; TOMITA K; MATUDA K; HISHIKAWA S
    Gan; 1955 Sep; 46(2-3):107-8. PubMed ID: 13262290
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification of the liver catalase-reducing substance occurring in cancer tissues, with special reference to its activity.
    NAKAGAWA S; KOSUGE T; TOKUNAKA H
    Gan; 1955 Dec; 46(4):585-96. PubMed ID: 13318221
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver catalase activity of patients with gastric cancer.
    OH-UTI K; MAKI K; ITO J; ANEHA Y; KOYAMA T
    Tohoku J Exp Med; 1958 Feb; 67(2-3):159-61. PubMed ID: 13556764
    [No Abstract]   [Full Text] [Related]  

  • 17. The inhibition of catalase by plasma and by human tissue extracts.
    Tudhope GR
    Clin Chim Acta; 1969 Sep; 25(3):379-87. PubMed ID: 4980646
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of the synthesis of catalase in liver of tumor-bearing mice by means of radioactive iron.
    CERIOTTI G; SPANDRIO L; AGRADI A
    Biochim Biophys Acta; 1958 Feb; 27(2):432-3. PubMed ID: 13522757
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modifications of catalase activity in the blood and liver punctates in cancer and precancer of the stomach; preliminary communication].
    BRAMBERGA VM
    Vopr Klin Lecheniia Zlokachestvennykh Novoobraz; 1956; 4():205-7. PubMed ID: 13468313
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of substances of tumor origin with inhibitory action on hepatic catalase in vivo. 3. Isolation, from ascites fluid, of proteins having anticatalase activity].
    CERIOTTI G; SPANDRIO L; AGRADI A
    Tumori; 1960; 46():486-93. PubMed ID: 13691968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.